How Is UnitedHealth Group's Stock Performance Compared to Other Healthcare Plan Stocks?

With a market cap of $352.7 billion, UnitedHealth Group Incorporated (UNH) is a diversified health care company operating globally through four main segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. Its businesses provide health benefit plans, care delivery, data and technology services, and pharmacy care solutions to individuals, employers, government programs, and health systems.

Companies valued at $200 billion or more are generally classified as “mega-cap” stocks, and Revvity fits this criterion perfectly. Based in Eden Prairie, Minnesota, the company serves a broad range of consumers and organizations across the health care ecosystem.

Shares of UnitedHealth Group have slipped 14.9% from its 52-week high of $461.62. The stock has risen 2.7% over the past three months, lagging behind the State Street SPDR S&P Health Care Services ETF’s (XHS) 16.6% gain over the same time frame.

Longer term, UNH stock is up 19% on a YTD basis, underperforming XHS’ 26.2% increase. Moreover, shares of the largest U.S. health insurer have soared nearly 30% over the past 52 weeks, compared to XHS’ 37% return over the same time frame.

Despite recent fluctuations, the stock has fallen below its 50-day moving average since mid-July. However, it has been trading above its 200-day moving average since last year.

Shares of UnitedHealth Group rose 1.2% on Jul. 16 after the company reported better-than-expected Q2 2026 adjusted EPS of $6.38 and revenue reached $112 billion. The strong results reflected better medical cost management, with the medical cost ratio improving to 86.7% and below the analyst estimate, alongside a 29% jump in Optum operating income to $4 billion. Investor confidence strengthened further after UnitedHealth raised its 2026 adjusted EPS outlook to $19.50 - $20.

In contrast, rival CVS Health Corporation (CVS) has slightly lagged behind UNH stock. CVS stock has gained 17.3% on a YTD basis and 29% over the past 52 weeks.

Due to UNH’s outperformance relative to its industry peers, analysts remain bullish about its prospects. The stock has a consensus rating of “Strong Buy” from 26 analysts in coverage, and the mean price target of $480.81 is a premium of 22.4% to current levels.